Halberd

Halberd Financial Debt Ratio

The Financial Debt Ratio of Halberd (HALB) as of Oct 17, 2026 is 3,343.74 %. In the previous year, Financial Debt Ratio was 1,480.60 % — a change of 125.84% (higher).

Financial Debt Ratio

3,343.74 %

YoY

125.84%

Last updated:

Financial Debt Ratio of Halberd is 2025 3,343.74 % . Financial Debt Ratio of Halberd was 2024 1,480.60 % . It decreases by 125.84% higher compared to the previous year.

The Halberd Financial Debt Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Debt Ratio
Date
Financial Debt Ratio
Jan 1, 2016
114.31 USD
Jan 1, 2017
109.77 USD
Jan 1, 2021
236.77 USD
Jan 1, 2022
877.55 USD
Jan 1, 2023
1,221.40 USD
Jan 1, 2024
1,480.60 USD
Jan 1, 2025
3,343.74 USD
The Halberd Financial Debt Ratio history
YEARFinancial Debt RatioYoY
3,343.74 %+125.84%
1,480.60 %+21.22%
1,221.40 %+39.18%
877.55 %+270.63%
236.77 %+115.69%
109.77 %-3.97%
114.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Financial Debt Ratio of Halberd is 3,343.74 % in 2025.

Financial Debt Ratio of Halberd changed from 1,480.60 % to 3,343.74 %, representing a 125.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Debt Ratio Halberd since 2006 – with annual values, charts, and detailed analysis.

The financial debt ratio measures interest-bearing financial debt as a percentage of total assets. It isolates funded debt from trade and other non-financial obligations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Debt Ratio's Halberd with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Halberd

All Key Metrics — Halberd